Skip to main content
OpenTrials
Completed

NCT Number: NCT07790692

Efficacy and Safety of Heated Chinese Herb Medicine Patch Therapy on Chemotherapy-Induced Aplastic Anemia

The objective of this clinical trial is to establish a treatment for chemotherapy-induced pancytopenia symptoms using heated traditional Chinese medicine (TCM) plasters through a randomized, single-blind clinical trial.

The primary question it aims to answer is whether heated TCM plasters improve chemotherapy-induced pancytopenia symptoms, maintain or increase white blood cells, platelets, and red blood cells, reduce the use of G-CSF and blood transfusions, and enhance cancer patients' quality of life. It also aims to assess if there are any adverse patient reactions to this treatment.

The researchers will compare heated TCM plasters with placebo heated/plaster, placebo TCM plasters, and placebo heated TCM plasters to determine whether the treatment improves chemotherapy-induced pancytopenia symptoms.

Participants will apply the plaster for 1 hour, once daily, 6 days a week for 2 consecutive weeks, totaling 12 applications. Full blood tests (Complete Blood Count, CBC) and white blood cell differential count (DC) will be performed before and after the treatment, and participants will complete the FACT-G cancer treatment-related quality of life scale.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Anemia Hematologic Diseases Hemic and Lymphatic Diseases Neoplasms

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Taichung armed forces gereral hospital

Taichung, Taiping District, 411228, Taiwan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients were eligible if they were:

(i) had a diagnosis of stage I-IV cancer. (ii) be aged 20 years or older. (iii)hematological dysfunction: have experienced a WBC count of <4000/μL or ANC <1500/μL after starting chemotherapy.

(iv) can understand and voluntarily sign the informed consent form t

Exclusion criteria

The following conditions disqualify participants from the study:

(i) Patients who are unsuitable for moxibustion, including those with wounds at the moxibustion site.

(ii)Individuals who refuse to sign the informed consent form. (iii) Minors, pregnant women, individuals with mental illnesses, those at risk of harm, or vulnerable groups.

(iv)Leukemia patients, as the disease itself affects blood cell changes. (v) Those who have used leukopoietic agents or received blood transfusions within the past month.

Treatment and study plan

The experimental group (heated TCM plaster group)

Other

Each time, 5g of the medicinal powder is combined with 7g of tap water and applied to gauze to form a medicinal cake. The researcher then places it on the Shenque point (International acupuncture point code: RN8). Additionally, a 3g moxa column with a 80:1 moxa wool ratio is ignited and placed in a moxibustion box to generate heat, which is layered over the medicinal cake for 1 hour. The treatment is applied once a day, 6 days a week, for 2 consecutive weeks, totaling 12 sessions.

Control group (sham heated TCM plaster group)

Other

The same acupuncture points and frequency are used, but instead of the medicinal cake, 5g of flour colored with caramel dye is applied. An unlit moxa column is placed in a moxibustion box to serve as a placebo heat source.

Heat source without TCM plaster group

Other

Only 3g of moxa wool (80:1 ratio) is ignited and placed in a moxibustion box to generate heat. The researcher directly applies it to the Shenque point for 1 hour, once a day, 6 days a week for 2 consecutive weeks, totaling 12 sessions. (If the participant feels it's too hot, they can either move the moxa wool around the Shenque point themselves or ask the researcher to do so to avoid burns.)

No heat source with TCM plaster group

Other

Only a TCM medicinal cake is applied to the Shenque point, with no heat source or moxibustion box used.

Primary outcomes

  1. Number of participants with abnormal blood tests results

    Time frame: Before the intervention (baseline, Day 1) and within 3 days after completion of the 12 intervention sessions(2 weeks).

    A complete blood count (CBC) and differential count (DC) will be performed by the hospital's Department of Laboratory Medicine. A 3 mL blood sample will be collected before and after the intervention, for a total of two blood draws. The test items are as follows:

Secondary outcomes

  1. "Traditional Chinese Medicine Constitution Questionnaire"

    Time frame: Before the intervention (baseline, Day 1)

  2. "FACT-G Quality of Life Questionnaire for Cancer Patients (Version 4)"

    Time frame: Before the intervention (baseline, Day 1) and after completion of the 12 intervention sessions (2 weeks)

    The Functional Assessment of Cancer Therapy-General Questionnaire(FACT-G)comprises 27 questions that assess four primary dimensions of QOL: physical (PWB; 7 items), social and family (SFWB; 7 items), emotional (EWB; 6 items), and functional well-being (FWB; 7 items). It uses 5-point Likert-type response categories ranging from 0 = 'not at all' to 4 = 'very much'. The total FACT-G score is the summation of the 4 subscale scores and ranges from 0 to 108. The higher scores in FACT-G mean a better or worse outcome.

  3. the number of G-CSF

    Time frame: the number of G-CSF used during the 12 intervention sessions period (at the end of this cycle, the cycle is 14 days).

  4. the number of blood transfusions

    Time frame: the number of blood transfusions used during the 12 intervention sessions period (at the end of this cycle, the cycle is 14 days).

Sponsors and collaborators

Lead sponsor

Hung-Rong Yen

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Aug 27, 2026
Registry last updated
Aug 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.